Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results

Core Insights - Delcath Systems, Inc. reported preliminary revenue results for Q3 2025, indicating a total revenue of approximately $20.5 million from its CHEMOSAT and HEPZATO KIT products [1] - The revenue breakdown shows HEPZATO KIT generated $19.2 million, while CHEMOSAT revenue was not fully disclosed [1] Financial Performance - Total revenue for CHEMOSAT and HEPZATO KIT reached around $20.5 million for the quarter ended September 30, 2025 [1] - HEPZATO KIT specifically contributed $19.2 million to the total revenue [1]